Publisher
Springer Science and Business Media LLC
Subject
Anesthesiology and Pain Medicine
Reference28 articles.
1. Centers for Disease Control and Prevention. Risks and how to reduce them. 2022. https://www.cdc.gov/opioids/patients/reduce-risks.html. Accessed 14 June 2023.
2. Centers for Disease Control and Prevention. Provisional Data Shows U.S. Drug Overdose Deaths Top 100,000 in 2022. 2023. https://www.cdc. gov/opioids/patients/reduce-risks.html. Accessed 14 June 2023.
3. Davis MP, Pasternak G, Behm B. Treating chronic pain: an overview of clinical studies centered on the buprenorphine option. Drugs. 2018;78(12):1211–28. https://doi.org/10.1007/s40265-018-0953-z.
4. Warner NS, Warner MA, Cunningham JL, Gazelka HM, Hooten WM, Kolla BP, et al. A practical approach for the management of the mixed opioid agonist-antagonist buprenorphine during acute pain and surgery. Mayo Clin Proc. 2020;95(6):1253–67. https://doi.org/10.1016/j.mayocp.2019.10.007. Provides a comprehensive review of buprenorphine and its different formulations and highlights management strategies.
5. Quaye A, Wampole C, Riker RR, Seder DB, Sauer WJ, Richard JM, et al. Buprenorphine continuation during critical illness associated with decreased inpatient opioid use in individuals maintained on buprenorphine for opioid use disorder in a retrospective study. J Clin Pharmacol. 2023; https://doi.org/10.1002/jcph.2286.